16 August 2024
Latham & Watkins Advises Avidity Biosciences on Upsized Public Offering of Common Stock
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Matt Bush Lead | Latham & Watkins LLP | Partner | corporate | San Diego |
| Cheston Larson Lead | Latham & Watkins LLP | Partner | corporate | San Diego |
| Nadia Patiño | Latham & Watkins LLP | Associate | corporate | Not stated |
| Madeleine West | Latham & Watkins LLP | Associate | corporate | Not stated |
Stated terms
- Stated value
- USD 300m (US$300.1 million)
- What the figure measures
- Issue size
- Client
- Avidity Biosciences, Inc.Issuer
- Counterparties
- underwriters (Underwriters)